Arrowhead Pharmaceuticals Inc (ARWR)
Solvency ratios
|
Sep 30, 2025 |
Jun 30, 2025 |
Mar 31, 2025 |
Dec 31, 2024 |
Sep 30, 2024 |
Jun 30, 2024 |
Mar 31, 2024 |
Dec 31, 2023 |
Sep 30, 2023 |
Jun 30, 2023 |
Mar 31, 2023 |
Dec 31, 2022 |
Sep 30, 2022 |
Jun 30, 2022 |
Mar 31, 2022 |
Dec 31, 2021 |
Sep 30, 2021 |
Jun 30, 2021 |
Mar 31, 2021 |
Dec 31, 2020 |
| Debt-to-assets ratio |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Debt-to-capital ratio |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Debt-to-equity ratio |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Financial leverage ratio |
2.97 |
2.66 |
2.30 |
19.28 |
6.15 |
2.67 |
1.97 |
3.90 |
2.82 |
2.18 |
1.99 |
2.36 |
6.53 |
1.66 |
1.56 |
1.71 |
1.74 |
1.68 |
1.70 |
1.10 |
Coverage ratios
|
Sep 30, 2025 |
Jun 30, 2025 |
Mar 31, 2025 |
Dec 31, 2024 |
Sep 30, 2024 |
Jun 30, 2024 |
Mar 31, 2024 |
Dec 31, 2023 |
Sep 30, 2023 |
Jun 30, 2023 |
Mar 31, 2023 |
Dec 31, 2022 |
Sep 30, 2022 |
Jun 30, 2022 |
Mar 31, 2022 |
Dec 31, 2021 |
Sep 30, 2021 |
Jun 30, 2021 |
Mar 31, 2021 |
Dec 31, 2020 |
| Interest coverage |
0.93 |
-0.91 |
-1.42 |
-12.34 |
-17.93 |
-22.89 |
-19.76 |
-13.56 |
-10.27 |
-11.49 |
-13.24 |
-22.37 |
-34.74 |
-16.29 |
-12.04 |
-18.68 |
-13.44 |
-0.01 |
-0.01 |
-0.01 |
